secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2025-03-28T23:59:59+00:00
Accession:  0000950170-25-046748
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biodesix receives Nasdaq deficiency notice for bid price below $1.00 per share
------------------------------------------------------------------------------

- Nasdaq notified Biodesix on March 24, 2025 that bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until September 22, 2025, to regain compliance with minimum bid price rule.
- To cure, closing bid price must be at least $1.00 for 10 consecutive business days before Compliance Date.
- If not cured by Sep 22, may be eligible for additional 180-day period on Nasdaq Capital Market if other standards met.
- Company may consider reverse stock split to increase bid price; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000095017025046748/0000950170-25-046748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000095017025046748/bdsx-20250324.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-046748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer